Checklist · Intellectual Property
Negotiating and Auditing an Intellectual Property License: A Practical Checklist
35 U.S.C. § 261
- Type
- Checklist
- Jurisdiction
- National
- Date
- 2024-03-26
- Topic
- Intellectual Property
This checklist walks through negotiating, papering, administering, and auditing an intellectual property license from first contact to wind-down. Phase one covers what to establish before a term sheet exists: what is actually owned, whether the rights are clear, and what the counterparty needs. Phase two covers the grant, scope, and economic terms, with specific attention to the definitions that generate disputes. Phase three covers the protective provisions — enforcement, insolvency, quality control, and termination. Phase four covers administration: reports, records, diligence tracking, and recordation. Phase five covers the royalty audit, from the trigger through the demand letter. A final phase covers diligence on someone else's license during a transaction.
Negotiating and Auditing an Intellectual Property License: A Practical Checklist
Intellectual Property > Licensing and Technology Transfer | Published 26 March 2024 - Updated 18 March 2025 | UpLaw - uplaw.us
How to Use This Checklist
Work the phases in order. Phases 1 through 3 run before signature, phase 4 runs for the life of the agreement, phase 5 runs when the numbers stop making sense, and phase 6 runs when someone is buying, selling, or lending against the license.
The doctrine behind each item is set out in licensing and technology transfer; the plain-language introduction is how intellectual property licensing actually works; the forms are in the IP licensing and royalty audit toolkit.
Phase 1 — Before There Is a Term Sheet
☐ Identify exactly what you own. List patents and applications by number, country, and status; copyright registrations by number and date; trademark registrations by number, class, and status; trade secrets by category, with a note on how each is protected.
☐ Confirm chain of title. Every assignment from every inventor or author, executed and recorded. Patent assignments record under 35 U.S.C. § 261 and 37 C.F.R. Part 3; trademark under 15 U.S.C. § 1060; copyright under 17 U.S.C. § 205.
☐ Check for co-owners. A patent co-owner can generally license without your consent. Resolve joint ownership by agreement before granting exclusivity you cannot deliver.
☐ Identify prior grants. Every existing license, option, right of first refusal, standards commitment, government interest, or security interest that narrows what you can grant now.
☐ Check federal funding. If any of the technology was developed with federal support, the Bayh-Dole regime applies: 35 U.S.C. § 200, 35 U.S.C. § 202, 35 U.S.C. § 203, and 37 C.F.R. Part 401. The government keeps a nonexclusive license; disclosure and election deadlines must have been met.
☐ Confirm ownership of employee and contractor work. Copyright vests initially in the author under 17 U.S.C. § 201 unless the work-made-for-hire definition at 17 U.S.C. § 101 applies or there is a signed transfer satisfying 17 U.S.C. § 204.
☐ Calculate copyright termination dates. For post-1977 grants, the 17 U.S.C. § 203 window opens thirty-five years after execution. For older grants, run 17 U.S.C. § 304. Know the earliest date before you value a long-dated license.
☐ Understand the counterparty's business. What does it actually need to make, use, sell, or import? A grant matched to the real use is narrower and easier to price than one drafted from a template.
☐ Sign a confidentiality agreement before technical disclosure, with a residuals clause you can live with and a term long enough to cover the negotiation and its aftermath.
☐ Decide your walk-away terms — minimum economics, non-negotiable field limits, and control provisions — before the first call. See drafting, reviewing, and enforcing a contract.
Phase 2 — The Grant and the Money
☐ Choose the grant type. Non-exclusive, sole, or exclusive. Only an exclusive licensee holding substantially all substantial rights can sue infringers alone, so a licensee that intends to police the market must negotiate for that.
☐ Write the grant sentence with the statutory rights named. For patents, the acts defined at 35 U.S.C. § 271. For copyright, the rights enumerated at 17 U.S.C. § 106. For trademarks, the use rights that support an infringement claim under 15 U.S.C. § 1114.
☐ Decide condition versus covenant for every limitation, and say which. A condition breached takes the licensee outside the grant, making the conduct infringement; a covenant breached is a contract claim.
☐ Define the field of use by enumerated list, not by adjective, and add a mechanism for expanding it.
☐ Define territory, and understand that an authorized sale exhausts, including abroad — Impression Products v. Lexmark Int'l, 581 U.S. 360.
☐ Set the term, and do not run a patent royalty past expiration unless the payment is genuinely consideration for something else.
☐ Reserve what you need: your own practice, research use, pre-existing licenses, government rights.
☐ Address sublicensing expressly. Permitted or not; on what conditions; what fraction of sublicense income flows up; whether sublicenses survive termination of the head license.
☐ Address assignment and change of control. This is the first provision an acquirer reads.
☐ Address improvements. Whose, which, for how long, on what terms.
☐ Pick the royalty structure: upfront, milestones, running royalty, minimums, equity, or a blend.
☐ Define net sales exhaustively. Enumerate every permitted deduction, require that it be actually taken, and cap deductions in the aggregate.
☐ Handle combination products with a stated apportionment formula.
☐ Include stacking relief with a floor.
☐ Set annual minimums tied to the exclusivity you are granting.
☐ Set diligence milestones with dates and consequences, including conversion from exclusive to non-exclusive.
☐ Specify reports: content, currency and conversion, timing, and officer certification.
☐ Specify audit rights: frequency, notice, independent accountant, record retention, survival period, and cost-shifting above a stated underpayment threshold.
☐ Set interest on late payments and a termination right for persistent nonpayment.
☐ Allocate withholding tax and gross-up obligations for cross-border payments.
Phase 3 — Protective Provisions
☐ Enforcement allocation. Who has the first right to sue, within what period, at whose cost, with what control over settlement, and how recoveries are divided. Add a step-in right if the first party declines.
☐ Settlement consent. Require consent before any settlement that grants rights under the licensed property, so a settlement cannot create a licensed competitor.
☐ Prosecution and maintenance. Who prosecutes, who pays maintenance fees, what consultation rights exist, and what happens if a party abandons.
☐ Validity challenge consequences. A licensee may challenge validity — Lear, Inc. v. Adkins, 395 U.S. 653 — and may do so without breaching first, per MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118. Price the challenge with a royalty step-up, fee-shifting, or a termination right rather than trying to forbid it.
☐ Trademark quality control, if any mark is licensed. Written standards, pre-launch approval, periodic inspection, and records. Without actual control the mark may be abandoned under 15 U.S.C. § 1127 and cancelled under 15 U.S.C. § 1064; the related-company benefit of 15 U.S.C. § 1055 depends on it. See drafting a trademark license agreement.
☐ Insolvency protection. An express acknowledgment of the licensee's election rights on rejection, plus escrow and a perfected security interest where the licensee's business depends on access. Rejection is breach, not rescission — Mission Product Holdings v. Tempnology, LLC, 587 U.S. 370 — and trademark licenses sit outside the statutory definition of intellectual property.
☐ Representations. Ownership, authority, no conflicting grants, no knowledge of invalidity, and — for federally funded technology — compliance with the disclosure and election obligations.
☐ Indemnity, with defined scope, control of defense, and caps.
☐ Limitation of liability, with carve-outs for confidentiality breach, indemnity, and willful misconduct.
☐ Confidentiality, surviving termination, with a carve-out for the licensee's independently developed information.
☐ Termination grounds enumerated: uncured material breach after notice, diligence failure, nonpayment, insolvency, and — if chosen — validity challenge.
☐ Cure periods calibrated to the default. Thirty days works for payment; quality control failures generally need longer, with diligent-effort language.
☐ Survival and wind-down. Sell-off period, return or destruction of materials, fate of sublicenses, surviving obligations, and continuing audit rights.
☐ Dispute resolution. For cross-border licenses, institutional arbitration seated in a New York Convention jurisdiction, with carve-outs for injunctive relief and validity.
☐ Export control representation and covenant where controlled technical data will be transferred.
☐ Antitrust and misuse sanity check. Scrutinize any royalty running past patent expiration, any exclusive royalty-free grant-back of independent improvements, and any restriction agreed between actual or potential competitors.
Phase 4 — Administration
☐ Record the assignment or security interest. Patent under 35 U.S.C. § 261 and 37 C.F.R. Part 3; trademark under 37 C.F.R. Part 2; copyright under 17 U.S.C. § 205. A copyright security interest is generally perfected at the Copyright Office, not by a state filing.
☐ Calendar everything: report due dates, payment dates, minimum payment dates, diligence milestones, maintenance fee windows, audit rights windows, renewal and termination notice dates.
☐ Keep the quality control file. Approvals granted, samples inspected, corrective actions requested and completed. The file, not the clause, wins a naked license challenge.
☐ Read every royalty report when it arrives. Compare unit volumes to public information, deduction percentages to the cap, and the sales trend to the licensee's public statements.
☐ Document every waiver in writing. An unwritten indulgence of a missed milestone becomes a course-of-dealing argument later.
☐ Track sublicenses. Copies delivered, income reported, obligations flowed through, consents obtained.
☐ Monitor the licensee's corporate status. A change of control that triggered a consent requirement and passed unnoticed is a common and expensive discovery.
☐ Confirm markings. Patent marking supports damages; see patent marking and constructive notice. Copyright notice practice is covered in copyright notice: a practical checklist.
Phase 5 — The Royalty Audit
☐ Identify the trigger. Falling royalties against rising public revenue; deduction percentages creeping toward the cap; a new product line that plausibly practices the patent but generates no royalty; a report format that changed; a missed report.
☐ Confirm your rights before you write. Audit frequency, notice period, permitted auditor, records covered, and how far back the retention obligation reaches.
☐ Send the notice letter, naming the accountant, the period, the records requested, and the proposed dates.
☐ Request the right records: general ledger extracts for the relevant accounts, sales registers by product and customer, credit memo and return detail, distributor agreements and transfer pricing, the product catalog with specifications, and reconciliations from the ledger to each royalty report.
☐ Reconcile from the top down. Total revenue in the financial statements, to the sales register, to the royalty base, to the reported figure. Explain every difference.
☐ Test the four classic underpayment sources: products excluded from the base that should be in it; deductions taken that the agreement does not permit or that were never actually incurred; combination product apportionment applied more aggressively than the formula allows; and sublicense or affiliate sales reported at an intercompany transfer price rather than the arm's-length price.
☐ Check currency conversion against the contract's stated source and date.
☐ Quantify, with interest, and separate undisputed from disputed amounts.
☐ Deliver a draft report to the licensee and let it respond before finalizing. Most disputes shrink at this step.
☐ Send the demand, attaching the reconciliation, invoking the cost-shifting threshold if it is met, and stating a deadline.
☐ Preserve the termination right if nonpayment continues, and give notice in the form the agreement requires.
Phase 6 — Diligence on Someone Else's License
☐ Read the grant sentence first, then the reserved rights, then the schedule of pre-existing licenses. Exclusivity is often less exclusive than the cover page suggests.
☐ Check assignment and change of control. If consent is required, identify who gives it and what they will want.
☐ Confirm payments are current and reports complete for the full audit period.
☐ Check diligence compliance, and look for missed milestones that were never waived in writing — an unexercised termination right is a repricing event.
☐ Trace improvements. Determine whether the technology developed after signing is inside or outside the grant.
☐ Verify recordation at the Patent and Trademark Office and Copyright Office, and search for prior unrecorded transfers or security interests.
☐ Check federal funding representations and any march-in exposure under 35 U.S.C. § 203, plus agency licensing authority under 35 U.S.C. § 207 and 35 U.S.C. § 209.
☐ Calculate copyright termination dates and compare them to the model's assumed term.
☐ Confirm quality control was actually exercised for any licensed mark.
☐ List every sublicense and confirm consents and survival terms.
☐ Read the litigation and correspondence file, which frequently contains the waiver, the notice of breach, or the standstill that the agreement itself does not disclose.
Common Mistakes
- Granting exclusivity you cannot deliver because a co-owner or prior licensee holds rights.
- Defining the field with an adjective instead of a list.
- Leaving deductions uncapped in the net sales definition.
- Omitting stacking relief.
- Failing to state whether a scope limit is a condition or a covenant.
- Writing a quality control clause and never exercising it.
- Waiving a diligence milestone informally.
- Ignoring the copyright termination clock in a long-dated valuation.
- Failing to record an assignment or perfect a security interest correctly.
- Structuring an audit right so expensive it is never used.
- Leaving sublicense survival unaddressed at termination.
- Treating a license as freedom to operate.
Related Documents
- Licensing and technology transfer: a comprehensive guide to scope, royalties, and termination
- Renting out an idea: how intellectual property licensing actually works
- The IP licensing and royalty audit toolkit
- Intellectual property licensing: a comprehensive guide to structuring and negotiating license agreements
- Building a patent license term sheet: a practical checklist
- Drafting a trademark license agreement: a practical checklist
- Drafting a copyright license agreement: a practical checklist
- Monetizing a patent through licensing: from valuation to term sheet
- Open source software compliance: a practical checklist
- Copyright renewal and termination of transfer: a practical checklist
- Auditing your trade secrets: a practical checklist
- Drafting, reviewing, and enforcing a contract: a practical checklist
- Patents: a comprehensive guide
- Anatomy of a software license agreement## Worked Example: The Audit That Paid for Itself
A university licensed a sensor patent exclusively for industrial process control. The licensee reported flat royalties for three years while its investor presentations described the product line as its fastest-growing segment. The licensor pulled the agreement and found a five percent underpayment threshold with cost-shifting, a three-year record retention obligation, and an annual audit right on thirty days' notice.
The notice letter named an accountant, the three most recent calendar years, and eleven categories of records. The reconciliation found three problems. First, a second-generation product had been treated as outside the licensed field on the theory that it used a different sensing element, when the field was defined by application rather than by technology. Second, the licensee had deducted a distributor "market development allowance" that the net sales definition did not list. Third, sales to a wholly owned foreign subsidiary had been reported at an intercompany transfer price, then resold at roughly double.
The draft report went to the licensee, which conceded the second and third items immediately and contested the first. The parties settled the field question by agreeing to a prospective rate reduction in exchange for payment of the disputed back royalty at the full rate. Total recovery exceeded the audit cost by a factor of eleven, and the cost-shifting threshold was met, so the licensee paid for the audit as well.
⭐ Key insight. The three findings in that audit are the three findings in most audits: product scope, unauthorized deductions, and affiliate transfer pricing. Test those first.
Worked Example: The Consent Nobody Asked For
A startup held an exclusive license to a diagnostic portfolio. Its acquisition closed on a Friday. The following Tuesday, the licensor sent a notice asserting that the merger was an assignment by operation of law, that consent had been required and not obtained, and that the license had terminated automatically.
The acquirer's diligence had flagged the assignment clause but concluded, without asking, that a reverse triangular merger left the licensee entity intact and therefore effected no assignment. The clause said "assignment, including by operation of law or change of control." That last phrase decided it.
The parties settled with a consent fee, an increased minimum, and a tightened diligence schedule. The lesson is procedural rather than doctrinal: where a consent clause is arguably triggered, the cost of asking before closing is a phone call, and the cost of not asking is measured in negotiating leverage lost at the worst possible moment.
Quick Reference: What Each Side Wants
| Provision | Licensor's position | Licensee's position |
|---|---|---|
| Grant | Narrow field, narrow rights | Broad field, all statutory rights |
| Exclusivity | Sole, with reserved practice | Fully exclusive, licensor excluded |
| Royalty base | Gross, few deductions | Net, generous deductions |
| Minimums | High, escalating | Low or none |
| Diligence | Dated milestones, hard consequences | Effort standards, renegotiation rights |
| Improvements | Broad grant-back | Licensor improvements included, none flowing back |
| Sublicensing | Consent required, high income share | Free right, low share |
| Enforcement | Licensor controls, licensee funds | Licensee controls, licensor cooperates |
| Assignment | Consent required, including change of control | Free to affiliates and acquirers |
| Termination | Broad grounds, short cures | Material breach only, long cures |
| Insolvency | Silence | Election acknowledgment, escrow, security interest |
Timing Reference
| Item | Typical timing | Consequence of missing it |
|---|---|---|
| Bayh-Dole invention disclosure | Within the contractor's stated period after conception | Loss of the right to elect title |
| Election of title | Within the statutory window after disclosure | Government may take title |
| Copyright termination notice | Two to ten years before the effective date, within the 17 U.S.C. § 203 window | Termination right lapses for that grant |
| Assignment recordation | Promptly; priority contest against a later purchaser | Junior priority under 35 U.S.C. § 261 |
| Royalty report | Contract period after each quarter | Breach; audit trigger |
| Audit notice | Within the contractual window each year | Right lapses for that period |
| Record retention | Contract period after the year audited | Audit becomes unprovable |
| Breach notice and cure | As specified | Termination right may be waived by delay |
Final Reminders
☐ Every economic term should be tested against four scenarios before signing: sale through a distributor at a transfer price; sale as a component of a larger system; acquisition of the licensee by a competitor; and invalidation of the most important patent.
☐ Every limitation should be labeled as a condition or a covenant.
☐ Every indulgence should be documented as a written waiver.
☐ Every administrative right — audit, inspection, approval, reporting — should be exercised at least once, on schedule, so that the practice matches the paper.
☐ Where the licensee's business depends on continued access, the insolvency package — express election acknowledgment, escrow with clear release triggers, and a perfected security interest — should be treated as a single item rather than three optional ones. Any one of the three alone leaves a gap the other two would have covered.
☐ Where the licensor is a university, a federal laboratory, or any recipient of federal support, run the Bayh-Dole items in Phase 1 before negotiating exclusivity. Those obligations sit above the agreement and cannot be bargained away between the parties.
☐ Before signing, read the whole document once more from the licensee's side and once from the licensor's, asking a single question at each provision: if the other party did the worst thing this clause permits, what would happen. That reading finds more problems in an hour than a redline exchange finds in a month.